<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<base href="SBA%203/17/25%20SCS">
<title>S3533 SCS</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 6 4 5 2 3 4;}
@font-face
	{font-family:Albertus;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.SubType, li.SubType, div.SubType
	{mso-style-name:SubType;
	margin-top:0in;
	margin-right:-.75in;
	margin-bottom:0in;
	margin-left:-1.0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:18.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.StateStyle, li.StateStyle, div.StateStyle
	{mso-style-name:StateStyle;
	margin-top:0in;
	margin-right:-.75in;
	margin-bottom:0in;
	margin-left:-1.0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:28.0pt;
	font-family:"Arial",sans-serif;
	letter-spacing:.2pt;
	font-weight:bold;}
p.SponsoredBy, li.SponsoredBy, div.SponsoredBy
	{mso-style-name:SponsoredBy;
	margin-top:0in;
	margin-right:-.75in;
	margin-bottom:0in;
	margin-left:-1.0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Arial",sans-serif;
	letter-spacing:.2pt;
	font-weight:bold;}
p.IndentHang, li.IndentHang, div.IndentHang
	{mso-style-name:IndentHang;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.25in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuComLine, li.bpuComLine, div.bpuComLine
	{mso-style-name:bpuComLine;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times",serif;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.PrefileFronterTitle, li.PrefileFronterTitle, div.PrefileFronterTitle
	{mso-style-name:PrefileFronterTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.RightBrackt
	{mso-style-name:RightBrackt;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StylePrefileFronterTitleLeft, li.StylePrefileFronterTitleLeft, div.StylePrefileFronterTitleLeft
	{mso-style-name:"Style PrefileFronterTitle + Left";
	margin-top:0in;
	margin-right:-.2in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Superscript
	{mso-style-name:Superscript;
	font-family:"Albertus",sans-serif;
	font-weight:bold;
	vertical-align:super;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.Style10ptRight-025, li.Style10ptRight-025, div.Style10ptRight-025
	{mso-style-name:"Style 10 pt Right\:  -0\.25\0022";
	mso-style-link:"Style 10 pt Right\:  -0\.25\0022 Char";
	margin-top:0in;
	margin-right:-.25in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.Style10ptRight-025Char
	{mso-style-name:"Style 10 pt Right\:  -0\.25\0022 Char";
	mso-style-link:"Style 10 pt Right\:  -0\.25\0022";
	letter-spacing:.2pt;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.BillFor, li.BillFor, div.BillFor
	{mso-style-name:BillFor;
	margin-top:0in;
	margin-right:-.75in;
	margin-bottom:0in;
	margin-left:-1.0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:18.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.BillPropBy, li.BillPropBy, div.BillPropBy
	{mso-style-name:BillPropBy;
	margin-top:0in;
	margin-right:-.75in;
	margin-bottom:0in;
	margin-left:-1.0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.5in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.2in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuComLine><a name=bpuFrontPg></a>SENATE COMMITTEE SUBSTITUTE FOR</p>

<p class=bpuBill>SENATE, No. 3533</p>

<p class=bpuWpGraphic></p>

<p class=bpuState>STATE OF NEW JERSEY</p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  <span style='line-height:120%;letter-spacing:0pt'>ADOPTED
MARCH 17, 2025</span></p>

<p class=bpuWpGraphic>&nbsp;</p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuWpGraphic>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Senator  ANGELA V. MCKNIGHT</p>

<p class=bpuSponsor>District 31 (Hudson)</p>

<p class=bpuSponsor>Senator  JON M. BRAMNICK</p>

<p class=bpuSponsor>District 21 (Middlesex, Morris, Somerset and Union)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>Co-Sponsored by:</p>

<p class=bpuSponsor>Senators Wimberly and Greenstein</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Establishes certain guidelines for SHBP, SEHBP, and
Medicaid concerning step therapy protocols. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     Substitute as adopted by the Senate Budget and
Appropriations Committee.</p>

<p class=bpuNormText>   </p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif;
letter-spacing:.2pt'><br clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><b><span style='font-variant:
small-caps'>An Act</span></b> concerning step therapy protocols and
supplementing Titles 30 and 52 of the Revised Statutes.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><b>     <span style='font-variant:
small-caps'>Be It Enacted</span></b><span style='font-size:10.0pt;line-height:
150%'> </span><i>by the Senate and General Assembly of the State of New Jersey:</i></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     1.    The
Legislature finds and declares that:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     a.     To
address the increasingly high cost of prescription drug utilization and to
address patient safety, health</span><sup> </sup><span style='color:black'>insurance</span><b><sup>
</sup></b><span style='color:black'>carriers and other plan sponsors use step
therapy protocols that require patients to try one or more prescription drugs
before coverage is provided for a drug selected by the patients health care
provider.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     b.    Step
therapy protocols, if based on well-developed scientific standards and
administered in a flexible manner that takes into account the individual needs
of patients, can play an important role in controlling health care costs.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     c.     Requiring
a patient to follow a step therapy protocol may have adverse and even dangerous
consequences for the patient, who may either not realize a benefit from taking
a prescription drug or may suffer harm from taking an inappropriate drug.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     d.    It
is imperative that step therapy protocols in the State preserve the heath care
providers right to make medically necessary treatment decisions in the best
interest of the patient.</span></p>

<p class=MsoNormal style='line-height:150%'>     e.     <span style='color:
black'>The Legislature declares, therefore, that it is a matter of public
interest that the State Health Benefits Program, the School Employers Health
Benefits Program, and NJ FamilyCare be required to base step therapy protocols
on appropriate clinical practice guidelines or published peer-reviewed data
developed by independent experts with knowledge of the condition or conditions
under consideration; that patients be exempt from step therapy protocols when
those protocols are inappropriate or otherwise not in the best interest of the
patients; and that patients have access to a fair, transparent and independent
process for requesting an exception to a step therapy protocol when the
patients physician deems appropriate.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     2.    As
used in sections 2 through 6 of this act:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     &quot;Division&quot;
means the Division of Medical Assistance and Health Services in the Department
of Human Services.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     &quot;Health
care provider&quot; means an individual or entity which, acting within the
scope of its licensure or certification, provides a covered service.  Health
care provider includes, but is not limited to, a physician and other health
care professionals licensed pursuant to Title 45 of the Revised Statutes, and a
hospital and other health care facilities licensed pursuant to Title 26 of the
Revised Statutes.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     Managed
care organization means a health maintenance organization contracted with the
division to provide benefits to Medicaid beneficiaries.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     Medicaid
means the program established pursuant to P.L.1968, c.413 (C.30:4D-1 et seq.).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     Medical
necessity&quot; or &quot;medically necessary&quot; means the same as those
terms are defined in section 4 of P.L.2023, c.296 (C.17B:30-55.3).</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     Step
therapy exception means the overriding of a step therapy protocol in favor of
immediate coverage of the health care providers selected prescription drug.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     Step
therapy protocol means a protocol, policy, or program that establishes the
specific sequence in which prescription drugs for a specified medical
condition, and medically appropriate for a particular patient, are required to
be administered in order to be covered by the division or a managed care
organization.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     3.    a. 
The division or a managed care organization shall require that clinical review
criteria used to establish a step therapy protocol under Medicaid are based on
clinical practice guidelines developed by the division, or a managed care
organization that:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (1)   recommend
that the prescription drugs be taken in the specific sequence required by the
step therapy protocol; </span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (2)   are
developed and endorsed by a multidisciplinary panel of experts that: </span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (a)   relies
on objective data; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (b)   manages
conflicts of interest among the members by requiring members to disclose any
potential conflict of interests with entities, including managed care
organizations, carriers, and pharmaceutical manufacturers and recuse themselves
from voting if they have a conflict of interest;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (3)   are
based on high quality studies, research, and medical practice;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (4)   are
created by an explicit and transparent process that:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (a)   minimizes
biases and conflicts of interest;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (b)   explains
the relationship between treatment options and outcomes;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (c)   rates
the quality of the evidence supporting recommendations; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (d)   considers
relevant patient subgroups and preferences; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (5)   
are reviewed annually or quarterly if there is a new indication or new clinical
information available and updated when such review reveals new evidence
necessitating modification.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     b.    In
the absence of clinical guidelines that meet the requirements in subsection a.
of this section, peer-reviewed publications may be substituted.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     c.     When
establishing a step therapy protocol, the division or managed care organization
shall also consider the needs of atypical patient populations and diagnoses
when establishing clinical review criteria.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     d.    A
managed care organization shall:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (1)   upon
written request, provide written clinical review criteria relating to a
particular condition or disease, including clinical review criteria relating to
a step therapy protocol exception determination; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (2)   </span>make
available the clinical review criteria and other clinical information on its
internet website and to a health care professional on behalf of an insured
person upon written request.</p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     e.     This
section shall not be construed to require managed care organizations or the
State to establish a new entity to develop clinical review criteria used for
step therapy protocols.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     4.    Notwithstanding
the provisions of any law, rule, or regulation to the contrary:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     a.     When
coverage of a prescription drug for the treatment of any medical condition is
restricted for use by a managed care organization pursuant to a step therapy
protocol, the managed care organization shall provide the enrollee and
prescribing practitioner a clear, readily accessible, and convenient process to
request a step therapy exception.  A managed care organization may use its
existing medical exceptions process to satisfy this requirement.  An
explanation of the process shall be made available on the managed care organizations
website.  A managed care organization shall disclose all rules and criteria
related to the step therapy protocol upon request to all prescribing
practitioners, including the specific information and documentation required to
be submitted by a prescribing practitioner or patient for an exception request
to be complete.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     b.    A
step therapy exception shall be granted if the prescribing health care provider
determines that:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (1)   the
required prescription drug is contraindicated or is likely to cause an adverse
reaction or physical or mental harm to the patient;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (2)   the
required prescription drug is expected to be ineffective or less effective than
an alternative based on the known clinical characteristics of the patient and
the known characteristics of the prescription drug regimen; or</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (3)   all
formulary drugs used to treat each disease state have been ineffective or less
effective than an alternative in the treatment of the enrollee's disease or
condition, or all such drugs have caused or are reasonably expected to cause
adverse or harmful reactions in the enrollee.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     If
requested by a managed care organization, the prescribing health care provider
shall provide documentation to support the determinations made by the provider
pursuant to paragraphs (1) through (3) of this subsection.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     c.     When
a step therapy exception is granted, the managed care organization shall
authorize coverage for the prescription drug prescribed by the patients
treating health care provider at least 180 days or the duration of therapy if
less than 180 days, provided that the prescription drug is covered under the
managed care organizations formulary.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     d.    Any
step therapy exception shall be eligible for appeal by an enrollee.  The
managed care organization shall grant or deny a step therapy exception request
or an appeal of a step therapy exception request within a time frame
appropriate to the medical exigencies of the case but no later than 24 hours
for urgent requests and 72 hours for non-urgent requests after obtaining all
necessary information to make the approval or adverse determination.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     e.     Any
step therapy exception pursuant to this section shall be eligible for appeal by
an enrollee.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     f.     This
section shall not be construed to prevent:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (1)   a
managed care organization from requiring a patient to try an AB-rated generic
equivalent, biosimilar, or interchangeable biological product prior to
providing coverage for the equivalent branded prescription drug;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (2)   a
managed care organization from requiring a pharmacist to effect substitutions
of prescription drugs consistent with the laws of this State; or</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (3)   a
health care provider from prescribing a prescription drug that is determined to
be medically appropriate.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     5.    A
managed care organization shall make statistics available regarding step
therapy exception request approvals and denials on its Internet website in a
readily accessible format, as determined by the Commissioner of Human Services,
or the commissioners designee.  The commissioner shall determine by regulation
the statistics and format of the statistics that are made available.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     6.    The
Commissioner of Human Services shall apply for such State plan amendments or
waivers as may be necessary to implement the provisions of this act and secure
federal financial participation for State Medicaid expenditures under the
federal Medicaid program. Prior to the implementation of this act, the
Commissioner of Human Services shall provide a separate rate certification for
this program and benefit change within the acute care and managed long-term
services and supports programs in compliance with federal standards including
but not limited to 42 C.F.R. 438.4.  Implementation of this program and benefit
change during the course of a state fiscal year shall require a mid-year
managed care rate adjustment for the acute care and managed long term services
and supports program.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     7.    As
used in sections 7 through 10 of this act:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     &quot;Covered
person&quot; means a person on whose behalf the State Health Benefits Program
or the School Employees' Health Benefits Program is obligated to pay benefits
or provide services pursuant to the health benefits plan.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     &quot;Health
benefits plan&quot; means a plan providing health care benefits coverage for
public employees and their dependents offered by </span>the State Health Benefits
Program or the School Employees Health Benefits Program.</p>

<p class=MsoNormal style='line-height:150%'>     &quot;Health care
provider&quot; means an individual or entity which, acting within the scope of
its licensure or certification, provides<span style='color:black'> a covered
service defined by the health benefits plan.  Health care provider includes,
but is not limited to, a physician and other health care professionals licensed
pursuant to Title 45 of the Revised Statutes, and a hospital and other health
care facilities </span>licensed pursuant to Title 26 of the Revised Statutes.</p>

<p class=MsoNormal style='line-height:150%'>     Medical necessity&quot; or
&quot;medically necessary&quot; means the same as those terms are defined in
section 4 of P.L.2023, c.296 (C.17B:30-55.3).</p>

<p class=MsoNormal style='line-height:150%'>     Step therapy exception means
the<span style='color:black'> overriding of a step therapy protocol in favor of
immediate coverage of the health care providers selected prescription drug.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     Step
therapy protocol means a protocol, policy, or program that establishes the
specific sequence in which prescription drugs for a specified medical
condition, and medically appropriate for a particular patient, are required to
be administered in order to be covered by a health benefits plan.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     Utilization
review organization means an entity that contracts with a vendor to conduct
utilization review.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     &quot;Vendor&quot;
means a third-party administrator that conducts claims administration, network
management, claims processing, or other related services for the State Health
Benefits Commission or the School Employees' Health Benefits Commission.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'> </span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     8.    a. 
A contract entered into by the State Health Benefits Commission or the School
Employees' Health Benefits Commission with a vendor shall require that clinical
review criteria used to establish a step therapy protocol are based on </span>clinical
<span style='color:black'>practice guidelines developed by the vendor that:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (1)   recommend
that the prescription drugs be taken in the specific sequence required by the
step therapy protocol;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (2)   are
developed and endorsed by a multidisciplinary panel of experts that: </span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (a)   relies
on objective data; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (b)   manages
conflicts of interest among the members by requiring members to disclose any
potential conflict of interests with entities, including vendors, carriers, and
pharmaceutical manufacturers and recuse themselves from voting if they have a
conflict of interest;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (3)   are
based on high quality studies, research, and medical practice;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (4)   are
created by an explicit and transparent process that:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (a)   minimizes
biases and conflicts of interest;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (b)   explains
the relationship between treatment options and outcomes;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (c)   rates
the quality of the evidence supporting recommendations; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (d)   considers
relevant patient subgroups and preferences; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (5)   
are </span>reviewed annually or quarterly if there is a new indication or new
clinical information available and <span style='color:black'>updated when such
review reveals new evidence necessitating modification.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     b.    In
the absence of clinical guidelines that meet the requirements in subsection a.
of this section, peer-reviewed publications may be substituted.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     c.     When
establishing a step therapy protocol, a utilization review agent shall also
consider the needs of atypical patient populations and diagnoses when
establishing clinical review criteria.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     d.    A
vendor shall:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (1)   upon
written request, provide written clinical review criteria relating to a
particular condition or disease, including clinical review criteria relating to
a step therapy protocol exception determination; and</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (2)   </span>make
available the clinical review criteria and other clinical information on its
internet website and to a health care professional on behalf of an insured
person upon written request.</p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     e.     This
section shall not be construed to require vendors or the State to establish a
new entity to develop clinical review criteria used for step therapy protocols.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     9.    Notwithstanding
the provisions of any law, rule, or regulation to the contrary:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     a.     When
coverage of a prescription drug for the treatment of any medical condition is
restricted for use by a vendor or utilization review organization pursuant to a
step therapy protocol, the vendor or utilization review organization shall provide
the covered person and prescribing practitioner a clear, readily accessible,
and convenient process to request a step therapy exception. A vendor or
utilization review organization may use its existing medical exceptions process
to satisfy this requirement. An explanation of the process shall be made
available on the vendor or utilization review organizations website.&nbsp; A
vendor or utilization review organization shall disclose all rules and criteria
related to the step therapy protocol upon request to all prescribing
practitioners, including the specific information and documentation required to
be submitted by a prescribing practitioner or patient for an exception request
to be complete.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     b.    A
step therapy exception shall be granted if the prescribing health care provider
determines that</span><span style='letter-spacing:.1pt'>:</span></p>

<p class=MsoNormal style='line-height:150%'>     (1)   the required
prescription drug is contraindicated or is likely to cause an adverse reaction
or physical or mental harm to the patient;</p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (2)   the
required prescription drug is expected to be ineffective or less effective than
an alternative based on the known clinical characteristics of the patient and
the known characteristics of the prescription drug regimen; or</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (3)   all
formulary drugs used to treat each disease state have been ineffective or less
effective than an alternative in the treatment of the covered person's disease
or condition, or all such drugs have caused or are reasonably expected to cause
adverse or harmful reactions in the covered person.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     If
requested by a vendor, the prescribing health care provider shall provide
documentation to support the determinations made by the provider pursuant to
paragraphs (1) through (3) of this subsection.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     c.     When
a step therapy exception is granted, the vendor or utilization review
organization shall authorize coverage for the prescription drug prescribed by
the patients treating health care provider at least 180 days or the duration
of therapy if less than 180 days</span><span style='letter-spacing:.15pt'>,
provided that the prescription drug is covered by the patients health benefits
plan.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     d.    Any
step therapy exception shall be eligible for appeal by a covered person.&nbsp;
The vendor or utilization review organization shall grant or deny a step
therapy exception request or an appeal of a step therapy exception request
within a time frame appropriate to the medical exigencies of the case but no
later than&nbsp;24 hours for urgent requests and 72 hours for non-urgent
requests after obtaining all necessary information to make the approval or
adverse determination.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     e.     Any
step therapy exception pursuant to this section shall be eligible for appeal by
a covered person.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     f.     This
section shall not be construed to prevent:</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (1)   a
vendor or utilization review organization from requiring a patient to try an
AB-rated generic equivalent, biosimilar, or interchangeable biological product
prior to providing coverage for the equivalent branded prescription drug;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (2)   a
vendor or utilization review organization from requiring a pharmacist to effect
substitutions of prescription drugs consistent with the laws of this State; or</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     (3)   a
health care provider from prescribing a prescription drug that is determined to
be medically appropriate.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     10.  A
vendor or utilization review organization shall make statistics available
regarding step therapy exception request approvals and denials on its Internet
website in a readily accessible format, as determined by the</span> <span
style='color:black'>State Treasurer, or the State Treasurers designee.  The
State Treasurer shall determine by regulation the statistics and format of the
statistics that are made available.</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span style='color:black'>     11.  This
act shall take effect on, and apply to all contracts and policies delivered,
issued, executed, or renewed on or after, January 1,</span><sup> </sup><span
style='color:black'>2026.</span> </p>

</div>

</body>

</html>
